24
views
0
recommends
+1 Recommend
2 collections
    0
    shares

          The flagship journal of the Society for Endocrinology. Learn more

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Unilateral hydrocephalus from a gangliocytoma-somatotrophinoma: first reported case

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Summary

          Although pituitary macroadenomas often cause mass effects on surrounding structures, it is extremely rare for pituitary lesions to disturb cerebrospinal fluid circulation. Sellar gangliocytoma-pituitary adenomas (SGPAs) are also extremely rare. Here we report the unique case of a man with the unusual combination of acromegaly from an SGPA, who presented with unilateral hydrocephalus. A 60-year-old man presented with rapid neurological deterioration, bitemporal hemianopia, and acromegalic features. Neuroimaging revealed a large sellar lesion extending superiorly into the left foramen of Monro, causing acute obstructive unilateral hydrocephalus. External ventricular drain placement improved consciousness immediately. Biochemical assessment confirmed acromegaly. Following trans-sphenoidal debulking, histology revealed a mixed gangliocytoma/sparsely-granulated somatotrophinoma. Despite the residual disease, his vision recovered remarkably, low-dose cabergoline controlled residual excess growth hormone (GH) secretion, and the residual tumour has remained extremely stable over 2 years. Hydrocephalus is an extremely rare complication of pituitary lesions, and unilateral hydrocephalus has never been reported previously. GH secretion in SGPAs is more common than for pituitary adenomas in general, raising questions regarding the aetiology and therapeutic approach to this rare combination tumour.

          Learning points
          • Pituitary tumours most commonly present with symptoms related to endocrine disturbance or mass effects upon visual pathways (e.g. optic chiasm, nerves in the lateral cavernous sinus). However, extremely rarely, pituitary masses may disrupt cerebrospinal fluid (CSF) circulation resulting in hydrocephalus.

          • Sellar gangliocytomas are very rare tumours and most of them are hybrid tumours with pituitary adenomas (SGPAs).

          • SGPAs are typically indolent and may be functioning or non-functioning tumours.

          • Growth hormone (GH)-producing SGPAs are less likely to respond to somatostatin agonists than classic somatotrophinomas.

          • Primary surgical debulking via a trans-sphenoidal approach was effective in this individual, leading to the restoration of CSF circulation and improvement in visual disturbance, while also negating the need for permanent CSF diversion despite the residual tumour burden.

          Related collections

          Most cited references14

          • Record: found
          • Abstract: found
          • Article: not found

          Acromegaly: an endocrine society clinical practice guideline.

          The aim was to formulate clinical practice guidelines for acromegaly.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            UPDATE ON THE CLINICOPATHOLOGY OF PITUITARY ADENOMAS

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Growth hormone tumor histological subtypes predict response to surgical and medical therapy.

              Growth hormone (GH) pituitary tumors are associated with significant morbidity and mortality. Current treatments, including surgery and medical therapy with somatostatin analogs (SSA), dopamine agonists and/or a GH receptor antagonist, result in disease remission in approximately half of patients. Predictors of GH tumor response to different therapies have been incompletely defined based on histologic subtype, particularly densely (DG) versus sparsely (SG) granulated adenomas. The aim of this study was to examine our own institutional experience with GH adenomas and correlate how subtype related to clinical parameters as well as response to surgery and medical therapies. A retrospective chart review of 101 acromegalic patients operated by a single neurosurgeon was performed. Clinical data were correlated with histologic subtype and disease control, as defined by IGF-1 levels, and random growth hormone levels in response to surgery and/or medical therapies. SG tumors, compared to DG, occurred in younger patients (p = 0.0010), were 3-fold larger (p = 0.0030) but showed no differences in tumor-invasion characteristics (p = 0.12). DG tumors had a higher rate of remission in response to surgery compared to SG, 65.7 vs. 14.3 % (p < 0.0001), as well as to medical therapy with SSAs (68.8 % for DG vs. 28.6 % for SG tumors; p = 0.028). SG tumors not controlled with SSAs consistently responded to a switch to, or addition of, a GH receptor antagonist. Histological GH tumor subtyping implicates a different clinical phenotype and biologic behavior, and provides prognostic significance for surgical success and response to medical therapies.
                Bookmark

                Author and article information

                Journal
                Endocrinol Diabetes Metab Case Rep
                Endocrinol Diabetes Metab Case Rep
                EDM
                Endocrinology, Diabetes & Metabolism Case Reports
                Bioscientifica Ltd (Bristol )
                2052-0573
                07 June 2021
                2021
                : 2021
                : 21-0037
                Affiliations
                [1 ]Department of Endocrinology and Diabetes , Faculty of Medicine, Royal Brisbane and Women’s Hospital, University of Queensland, Queensland, Australia
                [2 ]Kenneth J Jamison Neurosurgery Department , Royal Brisbane and Woman’s Hospital, Queensland, Australia
                [3 ]Pathology Queensland , Faculty of Medicine, Royal Brisbane and Women’s Hospital, University of Queensland, Queensland, Australia
                [4 ]Kenneth J Jamison Neurosurgery Department , Faculty of Medicine, Royal Brisbane and Woman’s Hospital, University of Queensland, Queensland, Australia
                [5 ]Department of Twin Research and Genetic Epidemiology , Faculty of Life Sciences and Medicine, King’s College London, London, UK
                [6 ]Faculty of Health and Medicine , Institute of Health and Biomedical Innovation, Queensland University of Technology, University of Queensland, Queensland, Australia
                Author notes
                Correspondence should be addressed to H Alexander; Email: hamish.alexander@ 123456health.qld.gov.au
                Author information
                http://orcid.org/0000-0002-2694-8612
                Article
                EDM210037
                10.1530/EDM-21-0037
                8284954
                34236040
                0920e3fc-84aa-4dbb-8bf6-02b4a6a1812d
                © The authors

                This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License..

                History
                : 28 April 2021
                : 07 June 2021
                Categories
                Adult
                Male
                White
                Australia
                Pituitary
                Pituitary
                Radiology/Rheumatology
                Surgery
                Unique/Unexpected Symptoms or Presentations of a Disease
                Unique/Unexpected Symptoms or Presentations of a Disease

                adult,male,white,australia,pituitary,radiology/rheumatology,surgery,unique/unexpected symptoms or presentations of a disease,july,2021

                Comments

                Comment on this article